Aprogenex Inc., of Houston, said its AproProbe Plusassay, a research product that includes DNA probes tosimultaneously identify fetal cells and analyzechromosomes within the cells, is available for sale inEurope.
Biomerica Inc., of Newport Beach, Calif., receivedFDA clearance for its non-radioactive Thyroxin (T4)microwell EIA test, which is one test in a multi-enzymatic thyroid panel the company plans to introduce.
Shield Diagnostics Ltd., of Dundee, Scotland, gainedFDA clearance for two ANCA (anti-neutrophilcytoplasmic antibodies) products in its DIASTAT range,bringing to 17 the number of FDA-approved tests in therange.
UroCor Inc., of Oklahoma City, completed a $4.1million private financing that consisted of the sale of823,320 shares at $5 each.
Zynaxix Inc., of Malvern, Pa., reached an agreementwith Intracel Corp., of Cambridge, Mass., to sell itsZymmune CD4/CD8 cell monitoring system. The valueof the deal is $2.1 million.
(c) 1997 American Health Consultants. All rights reserved.